ArticleJournal for immunotherapy of cancer2021

αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib.

Juemin Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.